Case Discussion: TB in Pregnancy December 15, 2010 E. Jane Carter, M.D.

Slides:



Advertisements
Similar presentations
TB/HIV Research Priorities: TB Preventive Therapy.
Advertisements

PDA is OK ….. Public/Private Doctor Agreement in Managing TB Cases Sandra Guerra-Cantu, MD, MPH Region 8 Medical Director.
TUBERCULOSIS. What is Tuberculosis? Tuberculosis (TB) is an infectious disease caused by the bacterium: “Mycobacterium tuberculosis”
Tuberculosis in Children: Prevention Module 10C - March 2010.
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
Prenatal Care in the YK Delta Ellen Hodges, MD Chief of Staff.
OSHA Blood Borne Pathogen and Tuberculosis Training PART II Tuberculosis Author: Maxine Edwards, RN, ICP ECU Infection Control Presented by: Patti Goetz,
Sheboygan County 2013 Sandy Muesegades, RN – Public Health Nurse.
Group Exercise Infection Control of Aerosol Transmissible Diseases.
Wyoming Department of Health Communicable Diseases
Interconception Education and Counseling: Strategies from Florida Presented by: Betsy Wood, BSN, MPH Infant, Maternal & Reproductive Health Unit Florida.
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
Unit 10 Treating the Dually Infected Patient: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Understanding and Preventing Tuberculosis Health, healing and hope.
Unit 5: IPT Isoniazid TB Preventive Therapy
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
NYU Medical Grand Rounds Clinical Vignette Demetrios Tzimas, PGY 2 October 27, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
HIV Testing In Vermont Update 2007 Cathleen Harris, MD Fletcher Allen Health Care.
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Unit 6 Diagnosing TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
TB Control Program County of San Diego Challenges: Cross border Continuity of TB Care Response:CureTBUS/Mexico Tuberculosis Referral and Information Program.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
Prenatal Care and Advocacy Susanna R Magee MD MPH Brown MOMS.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Progress of the Singapore TB Elimination Programme (STEP)
Tuberculosis in Virginia? Wendy Heirendt, MPA Public Health Advisor Division of TB Control Virginia Department of Health September 12, 2005.
Adult Medical-Surgical Nursing Respiratory Module: Tuberculosis.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
Bright Beginnings: An Activity of Project Blossom Kimberlee Wyche-Etheridge, MD, MPH Nashville, TN CityMatCH Conference.
By: Michelle Russell.  To become familiar with the disease process of TB Transmission symptoms Precautions  Nursing Diagnoses  Interventions.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
HIV/TB Integration in a Network of Voluntary Counseling/Testing Centers in HAITI Reynold Grand’Pierre MD, Marie Suze Jacquet MD, Jean W. Pape MD PEPFAR.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 7: GAP BETWEEN AVAILABILTY OF DRUG SUSCEPTIBILITY.
Kaiser Oakland Contact Investigation CTCA Conference May 6 th, 2010 Tara Greenhow, MD Pediatric Infectious Diseases Kaiser Permanente San Francisco.
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Incorporating Preconception Health into MCH Services
Pregnancy Complications. Rh Factor Incompatibility A condition that occurs during pregnancy if a woman has Rh-negative blood and her baby has Rh-positive.
New HIV Testing Requirements What Physicians Need to Know.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Acquired Drug Resistance  64 year old female of Hmong ethnicity with long standing, poorly controlled diabetes. No hx TB dx/tx.  11/6/08 CXR “active.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
Tuberculosis By Fion Kung. Objective  Describe tuberculosis  Describe sigh and symptoms of tuberculosis  Describe the nursing diagnosis for tuberculosis.
CPQC-HI MOM (Helping Infants with Mother’s Own Milk) Antenatal Platform Presentation November 10, 2015 Jodi Palmieri BSN, IBCLC St. Vincent’s Medical Center.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
ANTENATAL CARE.
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
Management of the Newborn When Maternal TB Suspected
Guidance on completion of Isoniazid Preventive Therapy register
My Birth Story Abby White.
Infant born with mother Tuberculosis
This is an archived document.
Treatment of Latent TB Infection (LTBI)
This is an archived document.
Mark Lobato, MD Division of TB Elimination
Marie Turner, M.D. Jo-Ann Keegan, R.N., M.S.N.
Case study: Maria 33 year old female pregnant with 3rd child
Tuberculosis Control Program
Presentation transcript:

Case Discussion: TB in Pregnancy December 15, 2010 E. Jane Carter, M.D.

Day of Referral 28 year old female referred to ENT for evaluation of progressive hoarseness Laryngoscopy demonstrated diffuse inflammation and granulomas Prescription given for steroids for inflammatory larnygitis She was pregnant – ENT immediately called OB to discuss case

History Related to ENT 29 weeks pregnant with twins 1 st Trimester: Significant heartburn, GERD and vomiting Vomiting resolved but GERD continued Hoarseness started at same time but has progressed to the point she can only whisper “Everything started with pregnancy.”

Why was TB clinic called? ENT called OB-GYN to discuss not only unusual differential but to inform about prednisone use OB noted the following history –Patient had a +TST performed in 1 st trimester of pregnancy –Appointment to RISE clinic on non-urgent basis for LTBI had been scheduled but had not occurred yet The phone call between the two MDs raised possibility of TB laryngitis ENT called TB clinic – same day appointment given

Why was she TST-ed? Born in India In the US 18 months Husband on a work visa –She is accompanying family –No screening performed previously TST performed as targeted testing strategy as part of the package of prenatal care

Back to the case – now at TB clinic No fevers, hemoptysis, or other constitutional findings Pre-pregnancy weight 103, now 116 Family reports “Not eating enough” Maybe a little cough PMH: none Meds: Zantac, prenatal vitamins

Work up at TB clinic Physical examination was unremarkable –Appeared tired but well –Afebrile –Gravid uterus HIV negative (already performed as part of prenatal care) CXR performed Sputum requested for AFB smears Prednisone treatment held

Minimal streaky infiltrate RUL

Next day Sputum was smear positive - rare

Treatment Regimen: Isoniazid, Rifampin, Ethambutol and B6 –Pyrazinamide deleted due to pregnancy Used throughout the world but not graded by FDA for safety in pregnancy Commits to longer course but regimen is still appropriate to prevent emergence of resistance

Public Health Quarantine initiated Plans needed to be made for ongoing OB care –No isolation room at private OB office Last appointment of the day with patient masked –Testing required at the obstetrical hospital Hospital notified; masking of patient; expedited appointments

Clinical Course Tolerated medications without difficulty Started gaining weight –22 pounds in 8 weeks DST returned fully susceptible –Ethambutol dropped Sputum collection every 2 weeks –Sputum smear conversion occurred at 4 weeks into treatment

IC Plan: Obstetrical Hospital Unclear if she would be non-contagious (culture negative) prior to delivery Plan designed by TB Clinic and approved by Infection Control at hospital –Private isolation room –Staff with PRP –No visiting to the newborn nursery –Placenta examined for granuloma –Window prophylaxis for babies if no disease noted –Husband no restrictions (CXR clear)

Outcomes - 1 Mom scheduled for c-section but went into labor 3 weeks early She was smear negative but not culture negative Placenta showed no granulomas Babies placed on window prophylaxis so they can re-unite with mom

Outcomes - 2 Mom’s cultures - taken 10 days prior to delivery. Eventually demonstrated no growth (no longer any risk of contagion) Babies taken off IPT at 6 weeks when this information discovered TST in babies at 12 weeks were both 0 mm Dad was not ignored –TST 15 mm at time of wife’s diagnosis –INH therapy simultaneous to Mom’s treatment

Outcomes - 3 Mom finishing her medications without difficulty –DOT –9 month treatment course (no PZA) Voice returned to near normal at 4 months into therapy

Lessons Learned - 1 Targeted testing strategies for LTBI can easily be incorporated into prenatal care In the era of declining TB rates in the US, diagnosis of disease requires awareness of at risk populations –Think TB!

Lessons Learned - 2 TB treatment in pregnancy is not only safe for mother and child but critically necessary for good outcomes Communication/cooperation between services is a critical component for good TB care –ENT-OB and then ENT-OB-TB Clinic –TB Clinic-Infection Control-OB Unusual presentation for TB laryngitis

Last lesson in TB control: Constant education is necessary! Despite detailed instructions to the OB hospital, –Father was made to wear a mask throughout admission (assumption was that he was also contagious!) –Staff wore N95 respirators throughout admission though “standard” infection control would have let her out of quarantine –Hospital originally charged patient for all her isolation facilities after health insurance denied charge due to “lack of medical necessity”

Questions or Comments?